MedPath

Nutrition, Diabetes and Pulmonary TB/HIV

Phase 3
Completed
Conditions
Tuberculosis
HIV
Diabetes
Interventions
Dietary Supplement: Multimicronutrients
Dietary Supplement: Energy and proteins
Registration Number
NCT00311298
Lead Sponsor
University of Copenhagen
Brief Summary

We propose a randomised trial among pulmonary TB patients, examined and treated as part of the national TB control programme (WHO, 2003). The aim is to improve TB treatment outcome in high TB and HIV burden countries. The overall objective of the proposed trial is to assess the effect of nutritional support on TB treatment outcomes, and to assess the role of diabetes on risk and severity of TB, and TB treatment outcomes. The study will be conducted in Mwanza Tanzania. All patients will initially be examined for HIV and diabetes. A total of 500 found pulmonary TB smear-positive (PTB+) and HIV positive (HIV+) will be randomised to a daily supplement of 1 versus 6 energy-protein bars throughout treatment, both with full multi-micronutrient (MN) content. A total of 1500 found pulmonary TB smear-negative (PTB-, irrespective of HIV status) and PTB+ and HIV negative (HIV-) will be randomised to 1 daily energy-protein bar containing either low or high MN content.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1250
Inclusion Criteria
  • New sputum smear positive or negative pulmonary TB patients
Exclusion Criteria
  • pregnant, terminally ill, other serious diseases (except HIV and diabetes), non-residents

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
No micronutrientsMultimicronutrientsBiscuit without additional micronutrients
MicronutrientsMultimicronutrientsBiscuit with additional micronutrients
1 biscuitEnergy and proteins1 biscuit with micronutrients
6 biscuitsEnergy and proteins1 biscuit with micronutrients, plus 5 biscuits without additional micronutrients
Primary Outcome Measures
NameTimeMethod
Weight gain2 and 5 months
Secondary Outcome Measures
NameTimeMethod
CD4 count2 and 5 months
Serum acute phase reactants2 months
Mortality12 month
Grip strength2 and 5 months
Arm muscle and arm fat areas2 and 5 months
Physical activity2 and 5 months
HIV load2 months

Trial Locations

Locations (1)

Mwanza Medical Centre, NIMR

🇹🇿

Mwanza, Tanzania

© Copyright 2025. All Rights Reserved by MedPath